• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

July 17, 2019

View Archived Issues

'CYRI, prevent that infection!'

Read More

Finding MDS' iron fist

Read More

New platform optimizes genome-editing enzyme activity

Read More

Ambrx announces initiation of phase I study of a long-acting relaxin

Read More

Novartis publishes first-in-human data for LYS-228

Read More

AMG-424 demonstrates promising activity in preclinical models of multiple myeloma

Read More

Teplizumab delays progression to clinical type 1 diabetes in relatives at risk

Read More

SAD study data on the anti-phospho-tau antibody JNJ-63733657 in healthy subjects presented

Read More

SHANK3-mutant macaque with altered connectivity and behavior as a model of autism spectrum disorder

Read More

PBD-C06: development candidate for immunotherapy against Alzheimer's disease

Read More

Druggability Technologies begins phase II trial of DRGT-119 for chronic anal fissure

Read More

Sichuan Kelun-Biotech Biopharmaceutical describes bile acid receptor agonists

Read More

mTORC1/mTORC2 inhibitor MTI-31 shows promise for treating lung cancer

Read More

Merck & Co. identifies PI3Kdelta inhibitors

Read More

Chiesi Farmaceutici divulges Rho kinase inhibitors

Read More

Boehringer Ingelheim patents SOS1 inhibitors

Read More

STING is required to restrict MCMV dissemination to lymph nodes

Read More

Bristol-Myers Squibb presents Toll-like receptor antagonists

Read More

Skyhawk and Genentech to discover and develop small-molecule RNA splicing modifiers

Read More

Affibody completes 12-week interim analysis of phase II psoriasis study of ABY-035

Read More

MDA funding supports development of small-molecule drugs to increase sarcospan expression for DMD

Read More

Mallinckrodt discontinues phase IIb study of Acthar gel in ALS

Read More

Researchers in search of small-molecule NAMPT activators for Alzheimer's disease

Read More

FDA clears investigator-initiated phase II trial of GKT-831 for IPF

Read More

Cyclica and University of Toronto enter EGFR inhibitor collaboration

Read More

FDA approves Recarbrio for complicated urinary tract and intra-abdominal infections

Read More

Invio cuts select early R&D programs to focus on HPV-related diseases

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe